Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis

Published:2021-09-24 Issue: Volume: Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

Peng Jingwen¹²^ORCID,Fu Meihua¹²,Mei Huan¹²,Zheng Hailin¹²,Liang Guanzhao¹²,She Xiaodong¹²,Wang Qiong¹²,Liu Weida¹²³^ORCID

Affiliation:

1. Department of Medical Mycology Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College Nanjing Jiangsu China

2. Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College Nanjing Jiangsu China

3. Center for Global Health School of Public Health, Nanjing Medical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2295

Reference27 articles.

1. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

2. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

3. Clinical efficacy of convalescent plasma therapy on treating COVID‐19 patients: Evidence from matched study and a meta‐analysis

4. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

5. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intolerance of uncertainty and internet addiction among college students in China post-pandemic era: the mediating role of future anxiety;Scientific Reports;2024-08-29

2. A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes;BioDrugs;2024-08-15

3. Does timing of tocilizumab administration affect mortality in COVID-19? A Scottish multicentre retrospective cohort study;BMJ Open Respiratory Research;2024-08

4. Comparison of the Results of BAL and ETA Culture in Intubated COVID-19 Patients;Nigerian Journal of Clinical Practice;2024-08

5. Post-COVID-19 Fungal Infections: A Case Series;Journal of Advanced Lung Health;2024-07-16